Home » GSK Signs on Astex in Partnership for About $33 Million
GSK Signs on Astex in Partnership for About $33 Million
GlaxoSmithKline (GSK) has inked a deal with Astex Therapeutics to discover, develop,
and commercialize compounds directed against multiple targets for £20
million (about $33 million) up front.
Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May